Cargando…
Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387890/ https://www.ncbi.nlm.nih.gov/pubmed/32742309 http://dx.doi.org/10.15420/ecr.2020.25 |
_version_ | 1783564214264135680 |
---|---|
author | Komiyama, Maki Hasegawa, Koji |
author_facet | Komiyama, Maki Hasegawa, Koji |
author_sort | Komiyama, Maki |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7387890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Radcliffe Cardiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-73878902020-07-30 Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019 Komiyama, Maki Hasegawa, Koji Eur Cardiol Covid-19 Radcliffe Cardiology 2020-07-15 /pmc/articles/PMC7387890/ /pubmed/32742309 http://dx.doi.org/10.15420/ecr.2020.25 Text en Copyright © 2020, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/legalcode This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly. |
spellingShingle | Covid-19 Komiyama, Maki Hasegawa, Koji Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019 |
title | Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019 |
title_full | Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019 |
title_fullStr | Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019 |
title_full_unstemmed | Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019 |
title_short | Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019 |
title_sort | response to the comment ‘smoking and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker cessation to limit coronavirus disease 2019 |
topic | Covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387890/ https://www.ncbi.nlm.nih.gov/pubmed/32742309 http://dx.doi.org/10.15420/ecr.2020.25 |
work_keys_str_mv | AT komiyamamaki responsetothecommentsmokingandangiotensinconvertingenzymeinhibitorangiotensinreceptorblockercessationtolimitcoronavirusdisease2019 AT hasegawakoji responsetothecommentsmokingandangiotensinconvertingenzymeinhibitorangiotensinreceptorblockercessationtolimitcoronavirusdisease2019 |